| Ident. | Authors (with country if any) | Title |
|---|
| 002E62 |
B. Hsu [États-Unis] ; C.-F. Chiou [États-Unis] ; S. Sheng [États-Unis] ; J. Smolen [Autriche] ; M. Weinblatt [États-Unis] | FRI0181 Sirukumab, a human anti-IL-6 monoclonal antibody, improves physical function in patients with active ra despite methotrexate therapy: Results from a 2-part, proof-of-concept, dose-ranging, randomized, double-blind, placebo-controlled, phase 2 study |
| 002F06 |
M. G Rtner [Autriche] ; F. Alasti [Autriche] ; G. Supp [Autriche] ; J. Smolen [Autriche] ; D. Aletaha [Autriche] | FRI0082 Radiographic progression in rheumatoid arthritis in the 21st century |
| 003112 |
J. Smolen [Autriche] ; M. Dougados [France] ; C. Gaillez ; C. Poncet [France] ; M. Le Bars ; A. Elegbe ; M. Schiff [États-Unis] | AB0543 Remission using different composite disease indices in MTX-IR RA patients treated with abatacept or infliximab, +MTX |
| 004133 |
M. Aringer [Allemagne] ; E. Feierl [Autriche] ; J. Smolen [Autriche] | Zytokinblockade – eine vielversprechende Therapieoption bei SLE |
| 004188 |
J. Smolen [Autriche] ; D. Aletaha [Autriche] | The burden of rheumatoid arthritis and access to treatment: a medical overview |
| 004245 |
R. N. Maini [Royaume-Uni] ; P. C. Taylor [Royaume-Uni] ; J. Szechinski [Pologne] ; K. Pavelka [République tchèque] ; J. Bröll [Autriche] ; G. Balint [Hongrie] ; P. Emery [Royaume-Uni] ; F. Raemen [Belgique] ; J. Petersen [Danemark] ; J. Smolen [Autriche] ; D. Thomson [Royaume-Uni] ; T. Kishimoto [Japon] | Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in european patients with rheumatoid arthritis who had an incomplete response to methotrexate |
